Carta Revisado por pares

A case of vancomycin‐induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC 16a domain of BP 180

2013; Wiley; Volume: 53; Issue: 3 Linguagem: Inglês

10.1111/ijd.12047

ISSN

1365-4632

Autores

Saki Tashima, Keisuke Konishi, Hiroshi Koga, Takashi Hashimoto,

Tópico(s)

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Resumo

International Journal of DermatologyVolume 53, Issue 3 p. e207-e209 Correspondence A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180 Saki Tashima MD, Saki Tashima MD [email protected] Department of Dermatology, Kyoto City Hospital, 1-2 Mibuhigashitakada-cho, Nakagyo-ku, Kyoto 604-8845 JapanSearch for more papers by this authorKeisuke Konishi MD, PhD, Keisuke Konishi MD, PhD Department of Dermatology, Kyoto City Hospital, 1-2 Mibuhigashitakada-cho, Nakagyo-ku, Kyoto 604-8845 JapanSearch for more papers by this authorHiroshi Koga MD, Phd, Hiroshi Koga MD, Phd Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, JapanSearch for more papers by this authorTakashi Hashimoto MD, PhD, Takashi Hashimoto MD, PhD Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, JapanSearch for more papers by this author Saki Tashima MD, Saki Tashima MD [email protected] Department of Dermatology, Kyoto City Hospital, 1-2 Mibuhigashitakada-cho, Nakagyo-ku, Kyoto 604-8845 JapanSearch for more papers by this authorKeisuke Konishi MD, PhD, Keisuke Konishi MD, PhD Department of Dermatology, Kyoto City Hospital, 1-2 Mibuhigashitakada-cho, Nakagyo-ku, Kyoto 604-8845 JapanSearch for more papers by this authorHiroshi Koga MD, Phd, Hiroshi Koga MD, Phd Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, JapanSearch for more papers by this authorTakashi Hashimoto MD, PhD, Takashi Hashimoto MD, PhD Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, JapanSearch for more papers by this author First published: 08 July 2013 https://doi.org/10.1111/ijd.12047Citations: 9Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Hirako Y, Nishizawa Y, Sitaru C, et al. The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini. J Invest Dermatol 2003; 121: 1554–1556. 10.1046/j.1523-1747.2003.12607.x CASPubMedWeb of Science®Google Scholar 2Hashimoto T, Ishiko A, Shimizu H, et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol 1996; 134: 336–39. 10.1111/j.1365-2133.1996.tb07624.x PubMedWeb of Science®Google Scholar 3Wozniak K, Hashimoto T, Fukuda S, et al. IgA anti-p200 pemphigoid. Arch Dermatol 2011; 147: 1306–1310. 10.1001/archdermatol.2011.303 PubMedWeb of Science®Google Scholar 4Paul C, Wolkenstein P, Prost C, et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997; 136: 406–411. 10.1046/j.1365-2133.1997.d01-1211.x PubMedWeb of Science®Google Scholar 5Wakelin SH, Allen J, Zhou S, et al. Drug-induced linear IgA disease with antibodies to collagen VII. Br J Dermatol 1998; 138: 310–314. 10.1046/j.1365-2133.1998.02081.x CASPubMedWeb of Science®Google Scholar 6Palmer RA, Ogg G, Allen J, et al. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol 2001; 145: 816–820. 10.1046/j.1365-2133.2001.04492.x CASPubMedWeb of Science®Google Scholar 7Armstrong AW, Fazeli A, Yeh SW, et al. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme. J Cutan Pathol 2004; 31: 393–397. 10.1111/j.0303-6987.2004.00190.x PubMedWeb of Science®Google Scholar 8Ishii N, Ohyama B, Yamaguchi Z, et al. IgA autoantibodies against the NC16a domain of BP180 but not 120-kDa LAD-1 detected in a patient with linear IgA disease. Br J Dermatol 2008; 158: 1151–1153. 10.1111/j.1365-2133.2008.08492.x CASPubMedWeb of Science®Google Scholar 9Schmidt E, Herzele K, Schumann H, et al. Linear IgA disease with circulating IgA antibodies against the NC16A domain of BP180. Br J Dermatol 1999; 140: 964–966. 10.1046/j.1365-2133.1999.02838.x CASPubMedWeb of Science®Google Scholar 10Zillikens D, Herzele K, Georgi M, et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180. J Invest Dermatol 1999; 113: 947–953. 10.1046/j.1523-1747.1999.00808.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume53, Issue3March 2014Pages e207-e209 ReferencesRelatedInformation

Referência(s)